FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015609042> ?p ?o ?g. }

• W2015609042 abstract "Gonorrhoea and widely spread antimicrobial resistance (AMR) in its etiological agent Neisseria gonorrhoeae are major public health concerns worldwide. Gonococcal AMR surveillance nationally and internationally, to identify emerging resistance and inform treatment guidelines, is imperative for public health purposes. In 2009, AMR surveillance was initiated in Belarus, Eastern Europe because no gonococcal AMR data had been available for at least two decades. Herein, the prevalence and trends of gonococcal AMR and molecular epidemiological characteristics of N. gonorrhoeae strains from 2010 to 2013 in Belarus, are described. N. gonorrhoeae isolates (n=193) obtained in the Mogilev (n=142), Minsk (n=36) and Vitebsk (n=15) regions of Belarus in 2010 (n=72), 2011 (n=6), 2012 (n=75) and 2013 (n=40) were analyzed in regards to AMR using the Etest method and for molecular epidemiology with N. gonorrhoeae multi-antigen sequence typing (NG-MAST). During 2010–2013, the proportions of resistant N. gonorrhoeae isolates were as follows: tetracycline 36%, ciprofloxacin 28%, penicillin G 9%, azithromycin 5%, and cefixime 0.5%. Only one (0.5%) β-lactamase producing isolate was detected. No isolates resistant to ceftriaxone and spectinomycin were identified. Overall, the resistance levels to tetracycline, ciprofloxacin and penicillin G were relatively stable. Interestingly, the level of resistance to azithromycin declined from 12% in 2010 to 0% in 2013 (P < 0.05). In total, 70 NG-MAST STs were identified. The predominant STs were ST1993 (n=53), ST807 (n=13), ST285 (n=8) and ST9735 (n=8). Many novel STs (n=43, 61%), representing 41% of all isolates, were found. During 2010–2013, the N. gonorrhoeae population in Belarus displayed high and relatively stable resistance levels to tetracycline, ciprofloxacin, and penicillin G, while the resistance to azithromycin declined. One isolate was resistant to cefixime, but no resistance to ceftriaxone or spectinomycin was found. The results of the present surveillance initiated in 2009 were also used to replace penicillin G with ceftriaxone (1 g single dose intramuscularly) as the first-line drug for empiric treatment of gonorrhoea in the national treatment guidelines in Belarus in late 2009. It is essential to further strengthen the surveillance of gonococcal AMR and ideally survey also treatment failures and molecular epidemiological genotypes in Belarus." @default.
• W2015609042 created "2016-06-24" @default.
• W2015609042 creator A5001552223 @default.
• W2015609042 creator A5029857499 @default.
• W2015609042 creator A5042513422 @default.
• W2015609042 creator A5042703537 @default.
• W2015609042 creator A5043166249 @default.
• W2015609042 creator A5049410703 @default.
• W2015609042 creator A5052676150 @default.
• W2015609042 creator A5059458426 @default.
• W2015609042 creator A5069892567 @default.
• W2015609042 creator A5079584948 @default.
• W2015609042 date "2015-01-31" @default.
• W2015609042 modified "2023-10-18" @default.
• W2015609042 title "Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010–2013" @default.
• W2015609042 cites W1543663755 @default.
• W2015609042 cites W1574656668 @default.
• W2015609042 cites W1714774926 @default.
• W2015609042 cites W172523583 @default.
• W2015609042 cites W1926560323 @default.
• W2015609042 cites W1967593111 @default.
• W2015609042 cites W1971326183 @default.
• W2015609042 cites W1976424859 @default.
• W2015609042 cites W1979622731 @default.
• W2015609042 cites W1982392457 @default.
• W2015609042 cites W1992306581 @default.
• W2015609042 cites W1994449629 @default.
• W2015609042 cites W2022572193 @default.
• W2015609042 cites W2056045684 @default.
• W2015609042 cites W2057866534 @default.
• W2015609042 cites W2067436228 @default.
• W2015609042 cites W2073004064 @default.
• W2015609042 cites W2080161439 @default.
• W2015609042 cites W2095104452 @default.
• W2015609042 cites W2095530067 @default.
• W2015609042 cites W2096919304 @default.
• W2015609042 cites W2105596926 @default.
• W2015609042 cites W2108798315 @default.
• W2015609042 cites W2109504052 @default.
• W2015609042 cites W2111450162 @default.
• W2015609042 cites W2118958699 @default.
• W2015609042 cites W2119904091 @default.
• W2015609042 cites W2122989236 @default.
• W2015609042 cites W2141108025 @default.
• W2015609042 cites W2149869281 @default.
• W2015609042 cites W2151985322 @default.
• W2015609042 cites W2152879488 @default.
• W2015609042 cites W2168286549 @default.
• W2015609042 cites W2170775843 @default.
• W2015609042 cites W2171521043 @default.
• W2015609042 cites W2171678337 @default.
• W2015609042 cites W2317407374 @default.
• W2015609042 cites W2328355973 @default.
• W2015609042 cites W2742378774 @default.
• W2015609042 cites W284167958 @default.
• W2015609042 cites W34855022 @default.
• W2015609042 doi "https://doi.org/10.1186/s12879-015-0755-9" @default.
• W2015609042 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4316755" @default.
• W2015609042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25637258" @default.
• W2015609042 hasPublicationYear "2015" @default.
• W2015609042 type Work @default.
• W2015609042 sameAs 2015609042 @default.
• W2015609042 citedByCount "29" @default.
• W2015609042 countsByYear W20156090422016 @default.
• W2015609042 countsByYear W20156090422017 @default.
• W2015609042 countsByYear W20156090422018 @default.
• W2015609042 countsByYear W20156090422019 @default.
• W2015609042 countsByYear W20156090422020 @default.
• W2015609042 countsByYear W20156090422021 @default.
• W2015609042 countsByYear W20156090422022 @default.
• W2015609042 countsByYear W20156090422023 @default.
• W2015609042 crossrefType "journal-article" @default.
• W2015609042 hasAuthorship W2015609042A5001552223 @default.
• W2015609042 hasAuthorship W2015609042A5029857499 @default.
• W2015609042 hasAuthorship W2015609042A5042513422 @default.
• W2015609042 hasAuthorship W2015609042A5042703537 @default.
• W2015609042 hasAuthorship W2015609042A5043166249 @default.
• W2015609042 hasAuthorship W2015609042A5049410703 @default.
• W2015609042 hasAuthorship W2015609042A5052676150 @default.
• W2015609042 hasAuthorship W2015609042A5059458426 @default.
• W2015609042 hasAuthorship W2015609042A5069892567 @default.
• W2015609042 hasAuthorship W2015609042A5079584948 @default.
• W2015609042 hasBestOaLocation W20156090421 @default.
• W2015609042 hasConcept C159047783 @default.
• W2015609042 hasConcept C174802600 @default.
• W2015609042 hasConcept C2776520383 @default.
• W2015609042 hasConcept C2778082588 @default.
• W2015609042 hasConcept C2778243283 @default.
• W2015609042 hasConcept C2778512257 @default.
• W2015609042 hasConcept C2778907293 @default.
• W2015609042 hasConcept C2779166590 @default.
• W2015609042 hasConcept C2780923616 @default.
• W2015609042 hasConcept C3013748606 @default.
• W2015609042 hasConcept C42972112 @default.
• W2015609042 hasConcept C4937899 @default.
• W2015609042 hasConcept C501593827 @default.
• W2015609042 hasConcept C71924100 @default.
• W2015609042 hasConcept C81396022 @default.
• W2015609042 hasConcept C86803240 @default.
• W2015609042 hasConcept C89423630 @default.

• next